Hospital staff at Montreal's Maisonneuve-Rosemont have raised concerns after a recent report identified cracks and probable asbestos in a five‑story clinical research pavilion. The staff claim the pavilion, which forms part of the older infrastructure at the facility, has been excluded from the institution's $5 billion modernization program.
The findings were highlighted in a report covered by La Presse, which noted structural deficiencies and the presence of materials that may pose health risks. According to the report, the pavilion shows visible cracking and indications of asbestos, a material commonly used in older construction that can become hazardous when disturbed.
Maisonneuve‑Rosemont Hospital is currently pursuing a multi‑billion‑dollar overhaul aimed at updating patient care areas, technology and building systems across the campus. The upgrade plan, valued at $5 billion, includes extensive renovations and new construction in several parts of the hospital. However, the clinical research pavilion has not been listed among the projects slated for renovation or replacement.
Hospital employees have publicly expressed disappointment that the deteriorating pavilion is not part of the current modernization agenda. Staff members argue that the building's condition could affect both research activities and overall safety, given the identified cracks and asbestos concerns. They contend that the omission leaves a critical piece of the hospital's infrastructure vulnerable.
Hospital administrators have not released a detailed response regarding the pavilion's status within the broader upgrade plan. The institution continues to move forward with its $5 billion investment, focusing on other priority areas while the pavilion remains unchanged.
The situation underscores the challenges faced by large health facilities when balancing extensive renovation budgets with the need to address aging structures. As the modernization proceeds, the fate of the clinical research pavilion remains an unresolved issue for staff and stakeholders at Maisonneuve‑Rosemont Hospital.